Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controlled studies of a new microprocessor-based portable infusion pump.

R T Dorr, S E Salmon, M E Marsh

    Cancer Drug Delivery
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hepatopathy in Victorian dogs consuming pet meat contaminated with indospicine.

    Australian veterinary journal·2022
    Same author

    Predicting the periodic risk of anthrax in livestock in Victoria, Australia, using meteorological data.

    International journal of biometeorology·2020
    Same author

    Classical swine fever in Victorian domestic pigs: evidence of disease freedom.

    Australian veterinary journal·2019
    Same author

    Immunologic Aspects of the Hematologic Neoplasms.

    Postgraduate medicine·2016
    Same author

    Chemistry and pharmacology of imexon and related cyanoaziridines.

    Current medicinal chemistry·2012
    Same author

    Adult rat myocardial slices: A tool for studies of comparative cardiotoxicity.

    Toxicology in vitro : an international journal published in association with BIBRA·2010

    The Provider IV 2000 portable infusion pump demonstrated excellent accuracy and reliability in delivering cancer therapies and pain management drugs. This microprocessor-controlled device is suitable for various clinical applications.

    Area of Science:

    • Medical Devices
    • Oncology
    • Pharmacology

    Background:

    • Portable infusion pumps are crucial for ambulatory cancer patients receiving continuous chemotherapy or pain management.
    • Evaluating the performance of new infusion devices is essential for patient safety and treatment efficacy.

    Purpose of the Study:

    • To assess the in vitro and in vivo performance of the microprocessor-controlled Pancretec Provider IV 2000 portable infusion pump.
    • To determine the accuracy, reliability, and clinical applicability of the Provider IV 2000 for continuous and intermittent infusions.

    Main Methods:

    • Bench testing of the Provider IV 2000 for flow rate accuracy and precision.
    • In vivo clinical studies involving 14 ambulatory cancer patients receiving continuous infusions over 5-60 days.

    Related Experiment Videos

  • Evaluation of pump performance, including therapy deviations and alarm functions.

    • Main Results:

    • In vitro tests showed flow rate accuracy within 96% and precision at +/- 2%.
    • Clinical studies demonstrated flow rate accuracy within +/- 5% in 90% of infusion courses (244 patient-days).
    • Three significant therapy deviations occurred, two due to fluid leakage, with alarms functioning correctly. Catheter patency was maintained with KVO rate.

    Conclusions:

    • The Pancretec Provider IV 2000 is an accurate and reliable portable infusion system.
    • The device exhibits wide clinical applicability for delivering antineoplastic and analgesic drugs.
    • The Provider IV 2000 represents a state-of-the-art infusion solution for outpatient therapy.